Background Previous research suggests that there may be similarities in structural brain
changes seen in patients with depression and psychosis compared to healthy controls …

Background Persistent negative symptoms (PNS) include both primary and secondary
negative symptoms that persist after adequate treatment, and represent an unmet …

Exosomes have been suggested as promising targets for the diagnosis and treatment of
neurological diseases, including schizophrenia (SCZ), but the potential role of exosome …

Introduction More than a century of research on the neurobiological underpinnings of major
psychiatric disorders (major depressive disorder [MDD], bipolar disorder [BD], schizophrenia …

Background: Previous research suggests that there may be similarities in structural brain
changes seen in patients with depression and psychosis compared to healthy controls …

Previous research has demonstrated aberrations in the levels of inflammatory cytokines in
patients with schizophrenia (SCZ), but most of the respective studies have tested a narrow …

Despite evidence of structural brain abnormalities in schizophrenia, the current study aimed
to explore the effects of antipsychotic treatment on gray matter (GM) volume using structural …

Background Grey matter (GM) reduction is a consistent observation in established late
stages of schizophrenia, but patients in the untreated early stages of illness display an …

We aimed to examine the hypotheses that glucolipid metabolism is linked to neurocognition
and gray matter volume (GMV) and that GMV mediates the association of glucolipid …

Objective Individuals with early psychosis may have prefrontal-limbic cortical deficits, which
are associated with symptom severity and cognitive impairment. This study investigated the …